Article

Repurposing the Memory-promoting Meclofenoxate Hydrochloride as a Treatment for Parkinson‘s Disease through Integrative Multi-omics analysis

2023-04-07

Abstract excerpt

Parkinson‘s disease (PD) is a devastating neurodegenerative disorder with growing prevalence worldwide and, as yet, no effective treatment. Drug repurposing promises to be invaluable for the identification of novel therapeutics for the treatment of PD due to the associated shortened drug development time, fewer safety concerns, and reduced costs. Here, we compiled gene expression data from 1,231 healthy human brai...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: da75740f-a7d7-537f-86cc-43dd2b75758b
DOI: 10.1101/2023.04.07.536024

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Repurposing the Memory-promoting Meclofenoxate Hydrochloride as a Treatment for Parkinson‘s Disease through Integrative Multi-omics analysisDOI 10.1101/2023.04.07.536024Read

Drug Repurposing for Parkinson’s Disease: A Large-Scale Multi-Cohort StudySemantic proximity Read

Identification of biomarkers associated with Parkinson’s disease by gene expression profiling studies and bioinformatics analysisSemantic proximity Read

Polypharmacological drug design opportunities against Parkinson's diseaseSemantic proximity Read

Identifying genetic targets in clinical subtypes of Parkinson’s disease for optimizing pharmacological treatment strategiesSemantic proximity Read

Common Dysregulated Pathways and Genes in Alzheimer’s, Parkinson’s, and Huntington’s Diseases: A Computational Analysis to Nominate Candidate Gene Targets for Drug RepurposingSemantic proximity Read

Constructing Parkinson's disease progression- endotype molecular networks for drug repurposing: multi-omics evidence aggregation and large-scale real-world data validationSemantic proximity Read

Integrated Analysis and Identification of Novel Biomarkers in Parkinson’s DiseaseSemantic proximity Read

Unveiling Sex-based Differences in Parkinson’s Disease: A Comprehensive Meta-analysis of Transcriptomic StudiesSemantic proximity Read

Transcriptional pathobiology and multi-omics predictors for Parkinson’s diseaseSemantic proximity Read

Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s DiseasesSemantic proximity Read

Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson’s diseaseSemantic proximity Read

Repositioning drugs by targeting network modules: a Parkinson's disease case study.Semantic proximity Read